3
Shared Docs
3
Same-Page
3 / 3
Mentions
ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges
his things I am doing. Thank you for your consideration. Kind regards, David David W. Carter President—DaCart Capital LW 1485 Main St Suite 301 St Helena, CA 94574 <DaCart Presentation Mar 2 2015.pptx> EFTA00351824
ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges
is things I am doing. Thank you for your consideration. Kind regards, David David W. Carter President—DaCart Capital LLC 1485 Main St Suite 301 St Helena, CA 94574 (510) 205-3175 Cell (707) 967-0556 Fax EFTA00351822
ly. It will be a challenge to find investors, sensitive to risk and return, to provide OvationBio the capital it needs to do its early work. Somehow OvationBio is what I thought you would find most interesting. Producing polyclonal antibodies from genetically modified chickens could solve one of the bigges
doing. Thank you for your consideration. Kind regards, David David W. Carter EFTA00351819 President—DaCart Capital LLC 1485 Main St Suite 301 St Helena, CA 94574 (510) 205-3175 Cell (707) 967-0556 Fax EFTA00351820
Entities connected to both OvationBio and St Helena

Jeffrey Epstein
PERSON
George W. Bush
PERSONJames Meiskin
PERSON
Lesley Groff
PERSONDavid Carter
PERSONRussian Venture Capital
ORGANIZATIONConcentRx
PERSON
Alan Dershowitz
PERSONPrediction
ORGANIZATIONRussian Venture
ORGANIZATION